Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for TKI-Associated Diarrhea in HER2+ Breast Cancer
NCT05773391Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2023
- Primary completion
- Aug 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, open-label trial of saccharomyces boulardii and gold_bifidum in diarrhea (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Diarrhea grading at 28 days. Status: unknown.
02
Drugs
saccharomyces boulardiigold_bifidum
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT05773391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05773391.